Health Care/Hospital

Global HealthTech Market will grow to US$ 456.85 Mn by 2028 at 19% CAGR- says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * The global healthtech market was valued atUS$ 96.11 Bn in 2019. The adoption of single use technology has experienced a rise in the healthcare industry durin...

2020-12-14 11:00 2214

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya "N...

2020-12-14 10:28 4165

Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium

TAIPEI and SAN DIEGO, Dec. 13, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer , announced their Abstract on Cholangiocarcinoma treatment with Silmit...

2020-12-14 10:09 1395

High prevalence of hospital malnutrition associated with poor clinical outcomes

BAD HOMBURG, Germany, Dec. 14, 2020 /PRNewswire/ -- Hospital malnutrition is documented in many observational studies fromthe United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in...

2020-12-14 10:00 1766

Global Respiratory Clinics Market will grow at a CAGR of 20.7% over the forecast period - says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ --   Respiratory Clinics Market will grow at a CAGR of 20.7% * In the United States currently more than 25 million people are diagnosed with asthma, because of thes...

2020-12-14 10:00 2126

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...

2020-12-14 09:00 1095

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...

2020-12-14 09:00 1950

Global Respiratory Care Devices Market was Valued at US$ 15527.49 Mn in 2019 Growing at a CAGR of 12.25% over the Forecast Period- says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * The COVID-19 pandemic is expected to have a positive impact on the global respiratory care devices market in the coming years. This is because of the increasin...

2020-12-14 09:00 1994

The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention

GENEVA and CASTRES , France, Dec. 14, 2020 /PRNewswire/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked...

2020-12-14 09:00 1625

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed') is a global innovative biopharmaceutical company. HopeMed recently announced that the current Chairman of the Scientific Advisory Board, DrHenri Nico Doods, will serve as the company's President, as well as Head of Research & ...

2020-12-14 09:00 4872

Gannex Received U.S. FDA Fast Track Designation for Its NASH Drug Candidate ASC42,an FXR Agonist

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced today that it received Fast Track designation from the U.S. Food and Drug Administration (F...

2020-12-14 08:30 2544

Global Healthcare Service Robots Market will grow to US$ 3091.18 Mn by 2028 at a CAGR of 15.7% over the forecast period - says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * Global healthcare service robots market was estimated to beUS$ 512.09 million in 2019 and is expected to reach US$ 3091.18 million by 2028. Request for Samp...

2020-12-14 08:00 1928

Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021

SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...

2020-12-14 07:30 4269

Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates

SUZHOU, China, Dec. 12, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for the treatment of COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutica...

2020-12-12 11:02 12315

Secret behind speedy construction of Huoshenshan and Leishenshan hospitals

BEIJING, Dec. 11, 2020 /PRNewswire/ -- A news report by China.org.cn: At the beginning of 2020, billions of netizens at home and abroad joined online and cheered for the speedy construction of two hospitals inWuhan. It was during the Spring Festival when CSCEC built two emergency hospitals – Huo...

2020-12-12 00:00 3300

PharmaBlock Enters Strategic Partnership with Ascentage Pharma

NANJING, China, Dec. 11, 2020 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (300725.SZ), a leading innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced the signing of a strategic partnership agreement with Ascentage Pharma (6855.HK), a glob...

2020-12-11 21:00 6369

BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media DARMSTADT, Germany and NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE)  today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion rec...

2020-12-11 21:00 6167

Kintor Pharmaceutical Announces Preliminary Results from the Proxalutamide's Clinical Trial

SUZHOU, China, Dec. 11, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutical and is currentl...

2020-12-11 19:44 9022

BookDoc won the Pfizer and Alibaba jointly organized competition - Healthcare Fintech Alliance (HFA) Innovation Challenge, Asia

KUALA LUMPUR, Malaysia, Dec. 11, 2020 /PRNewswire/ -- BookDoc, a home-grown Malaysian health-tech company (with presence in 5 countries and 20 cities, MY, SG, HK, TH, IND), has again been recognised as the top health-tech company acrossAsia, battling over 100 other participants across Asia. The c...

2020-12-11 17:38 3100

Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer

SAN FRANCISCO and SUZHOU, China, Dec. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2020-12-11 09:02 6971
1 ... 581582583584585586587 ... 807